Wells Fargo’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNY
TI
WCM
MCA
FFA
KCM
AAS
Wells Fargo's MRNY Position: Q2 2026 in Review
Wells Fargo reduced its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 50% in Q2 2026, selling an estimated $17 and leaving 1 share worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #7051.
Wells Fargo first reported a position in MRNY in Q1 2026 and has held it in 2 quarters since. The position peaked at $31 in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.
- Wells Fargo held 1 share of YieldMax MRNA Option Income Strategy ETF worth $11 as of Q2 2026.
- Wells Fargo sold 1 YieldMax MRNA Option Income Strategy ETF share in Q2 2026, an estimated $17.
- YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #7051 holding.
- Wells Fargo first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2026 and has held it in 2 quarters since.
- Wells Fargo's YieldMax MRNA Option Income Strategy ETF position peaked at $31 in Q1 2026.
- 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.